Leerink Partnrs Issues Pessimistic Outlook for MRK Earnings

Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities researchers at Leerink Partnrs lowered their FY2026 EPS estimates for Merck & Co., Inc. in a research note issued on Monday, November 10th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will post earnings of $8.46 per share for the year, down from [...]

Read Full Article →